Sigrún Þorsteinsdóttir

Iceland screens, treats, or prevents multiple myeloma (iStopMM): a population-based screening study for monoclonal gammopathy of undetermined significance and randomized controlled trial of follow-up strategies

Sæmundur Rögnvaldsson, Þorvarður Jón Löve, Sigrún Þorsteinsdóttir et al. · Blood Cancer Journal · 2021 · 109 citations · Full text

Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study

Þórir Einarsson Long, Ólafur S. Indridason, Runólfur Pálsson et al. · Blood Cancer Journal · 2022 · 107 citations · Full text

Prevalence of smoldering multiple myeloma based on nationwide screening

Sigrún Þorsteinsdóttir, Gauti Kjartan Gíslason, Thor Aspelund et al. · Nature Medicine · 2023 · 73 citations · Full text

Hematological Malignancy, Oncology, Cancer Screening +3

Fractures and survival in multiple myeloma: results from a population-based study

Sigrún Þorsteinsdóttir, Thor Aspelund, Ingigerður Sverrisdóttir et al. · Haematologica · 2019 · 63 citations · Full text

Bone Disease, Skeletal Trauma, Hematological Malignancy +12

Comorbidities in multiple myeloma and implications on survival: A population‐based study

Ingigerður Sverrisdóttir, Sölvi Rögnvaldsson, Sigrún Þorsteinsdóttir et al. · European Journal Of Haematology · 2021 · 35 citations

Prognosis, Myeloid Neoplasia, Hematological Malignancy +16